Skip to main content
logo
Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.1900
-0.0050 (-2.56%)
Aug 26, 2026, 4:10 PM AEST

Argenica Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
241298973737
Market Cap Growth
-72.26%-87.37%0.85%162.45%-1.32%155.40%
Enterprise Value
19783882932
Last Close Price
0.190.100.760.780.380.43

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
4.282.1730.3837.2621.08144.26
PB Ratio
4.132.0913.496.944.814.50
P/TBV Ratio
4.142.0913.496.944.814.50

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
3.401.2825.6834.0216.43123.78

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-1.08-1.08-1.46-1.14-1.22-1.07
Asset Turnover
0.650.650.230.200.190.03
Quick Ratio
10.5110.512.896.715.0612.21
Current Ratio
10.6010.602.906.755.0912.29
Return on Equity (ROE)
-20.78%-20.78%-67.68%-50.70%-60.29%-53.99%
Return on Assets (ROA)
-9.72%-9.72%-35.03%-27.35%-32.79%-31.35%
Return on Capital Employed (ROCE)
-23.10%-23.10%-106.20%-40.70%-63.60%-49.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-5.59%-11.07%-7.34%-5.66%-13.05%-10.95%
Buyback Yield / Dilution
3.06%2.67%-22.97%-40.29%--108.80%